Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Sep. 29, 2012	Sep. 24, 2011	Sep. 25, 2010
Cash flows from operating activities:
Net income	$ 363,500	$ 201,048	$ 79,506
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation	135,656	72,297	29,484
Amortization of intangibles	45,991	41,339	14,973
Amortization deferred financing fees	6,050	6,158	862
Loss on extinguishment of debt		19,732
Unrealized (gain) loss of foreign currency	(6,557)	1,041
Loss on disposal of fixed assets	2,517	884	573
Gain on sale of subsidiary, excluding transaction costs	(28,914)
Provision for doubtful accounts	3,197	2,584	610
Provision for sales returns	107,436	64,457	40,139
Unrealized loss (gain) on financial instruments, net	6,310	3,292	(188)
Tax benefit from exercise of non-qualified options and disqualified dispositions of incentive stock options	(1,006)	(6,142)	(713)
Excess tax benefits from equity-based compensation plans	(12,070)	(67,813)	(14,590)
Deferred income taxes	60,856	(8,828)	(6,931)
Deferred compensation and stock compensation	18,079	10,575	8,110
Contributions to the ESOP			1,376
Other	334
Changes in assets and liabilities, net of effects of acquisition:
Receivables	(159,317)	(157,329)	(102,297)
Inventories	(92,862)	(375,709)	(116,653)
Income tax receivable/payable, net	16,457	63,487	10,065
Other current assets	(6,900)	(715)	(10,692)
Other long-term assets, net	(469)	(11,454)	(5,349)
Accounts payable	(17,668)	106,202	41,007
Accrued compensation costs	(4,908)	2,233	(1,830)
Accrued expenses	39,701	25,600	23,405
Other current liabilities	(2,718)	(3,118)	1,645
Other long-term liabilities	5,090	10,964	5,191
Net cash provided by (used in) operating activities	477,785	785	(2,297)
Cash flows from investing activities:
Change in restricted cash	(2,875)	2,074	(75)
Proceeds from sale of short-term investments			50,000
Proceeds from the sale of subsidiary, net of cash acquired	137,733
Capital expenditures for fixed assets	(401,121)	(283,444)	(126,205)
Other investing activities	618	1,533	2,314
Net cash used in investing activities	(265,645)	(1,187,672)	(533,435)
Cash flows from financing activities:
Net change in revolving line of credit	(108,727)	333,835	145,000
Proceeds from issuance of common stock under compensation plans	12,092	17,328	8,788
Proceeds from issuance of common stock for private placement		291,096
Proceeds from issuance of common stock for public equity offering		673,048
Financing costs in connection with public equity offering		(25,685)
Repurchase of common stock	(76,470)
Excess tax benefits from equity-based compensation plans	12,070	67,813	14,590
Payments on capital lease and financing obligations	(7,558)	(8)	(217)
Proceeds from borrowings of long-term debt		796,375	140,000
Deferred financing fees		(46,009)	(1,339)
Repayment of long-term debt	(7,814)	(906,885)	(8,500)
Other financing activities	3,283	(1,063)
Net cash (used in) provided by financing activities	(173,124)	1,199,845	298,322
Change in cash balances included in current assets held for sale	5,160	(5,160)
Effect of exchange rate changes on cash and cash equivalents	1,124	790
Net increase (decrease) in cash and cash equivalents	45,300	8,588	(237,410)
Cash and cash equivalents at beginning of period	12,989	4,401	241,811
Cash and cash equivalents at end of period	58,289	12,989	4,401
Supplemental disclosures of cash flow information:
Cash paid for interest	20,783	33,452	6,486
Cash paid for income taxes	136,407	58,182	42,313
Fixed asset purchases included in accounts payable and not disbursed at the end of each year	56,127	25,737	20,261
Noncash financing and investing activity:
Fixed assets acquired under capital lease and financing obligations	66,531
Noncash investing activity:
Liabilities assumed in conjunction with acquisitions			$ 1,533